BVNRY Stock Price Chart
BVNRY Earnings
Bavarian Nordic A/S
$9.09
-0.98%
$-0.08
At close: Aug 07, 16:00:00 GMT-4
$9.09
0%
$0
Post-market: Aug 07, 20:00:00 GMT-4
Back
Bavarian Nordic A/S (BVNRY) Earnings
Latest Earnings Results: Q1 '26
Reported: 2026-05-13
Historical Earnings
Quarterly
Annual
EPS
Revenue
Earnings FAQ
How did BVNRY's recent EPS compare to expectations?
How did Bavarian Nordic A/S BVNRY's revenue perform in the last quarter?
What is the revenue estimate for Bavarian Nordic A/S?
What's the earning quality score for Bavarian Nordic A/S?
When does Bavarian Nordic A/S report earnings?
What are Bavarian Nordic A/S's expected earnings?
Did Bavarian Nordic A/S beat earnings expectations?
Key Stats
Prev.Close
$9.18
Open
$9.18
Day's Range
$9.09 - $9.18
52 week range
$8.67 - $13
Volume
200
Avg.Volume
3.6K
Dividend yield
--
EPS (TTM)
0.77
Market Cap
$2.0B
What is Bavarian Nordic A/S?
Bavarian Nordic A/S engages in the business of developing, manufacturing, and commercializing cancer immunotherapies and vaccines for infectious diseases. The firm is involved in research and development innovations, production and commercialization of life-saving vaccines based on viral vectors for the delivery of antigens targeting infectious diseases. Bavarian Nordic A/S offers travel health products including cholera, rabies, tick-borne encephalitis and typhoid vaccines, as well as vaccines sold and distributed in selected markets on behalf of third parties. The firm deals with vaccines aimed at improving public health and preparedness. Bavarian Nordic A/S focuses on vaccine solutions that help address the threat of infectious diseases. The firm operates worldwide.
